Related Experiment Video
Updated: Mar 23, 2026

Discrimination of Seven Immune Cell Subsets by Two-fluorochrome Flow Cytometry
Published on: March 5, 2019
Multi-color immune-phenotyping of CD34 subsets reveals unexpected differences between various stem cell sources.
J Dmytrus1, S Matthes-Martin2, H Pichler2
1Children's Cancer Research Institute, Vienna, Austria.
This study introduces a multi-color flow cytometry assay to differentiate CD34+ hematopoietic stem and progenitor cell subsets. The assay reveals distinct subset compositions in peripheral blood stem cells, donor bone marrow, and post-allograft bone marrow, impacting engraftment predictions.
Area of Science:
- Hematology
- Immunology
- Cell Biology
Background:
- Routine CD34 analysis enumerates hematopoietic stem and progenitor cells but overlooks critical subpopulations.
- Understanding CD34+ cell subset composition is crucial for predicting engraftment dynamics and immune reconstitution after transplantation.
Purpose of the Study:
- To establish and validate a multi-color flow cytometry assay for detailed CD34+ cell subset phenotyping.
- To compare the CD34+ subset composition in peripheral blood stem cells (PBSC), donor bone marrow (BMd), and bone marrow one year post-allografting (BM1y).
Main Methods:
- Development of a multi-color flow cytometry assay using antibodies against CD133, CD45RA, CD10, CD38, and CD33.
- Analysis of CD34+ cell subsets in PBSC, BMd, and BM1y samples.
Main Results:
- Significant differences in CD34+ subset composition were observed across sample types.
- Early progenitor subpopulations (CD45RA(-)CD133(+)CD38(low)) were more frequent in PBSC than BMd and rare in BM1y.
- Committed CD34+ precursors, including B-lymphoid precursors (CD38(++)), were most abundant in BM1y.
- Differential CD33 expression intensity aided in distinguishing myeloid precursor maturation stages.
Conclusions:
- The developed multi-color phenotyping assay provides a qualitative approach to define diverse CD34+ subtypes.
- This detailed phenotyping offers potential for improved prediction of engraftment kinetics and immune reconstitution.
- Further studies are required to validate the clinical impact of this advanced assay.
More Related Videos
09:34A Combinatorial Single-cell Approach to Characterize the Molecular and Immunophenotypic Heterogeneity of Human Stem and Progenitor Populations
Published on: October 25, 2018
12:03Phenotypic Analysis and Isolation of Murine Hematopoietic Stem Cells and Lineage-committed Progenitors
Published on: July 8, 2012